# A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo

> **NCT04818346** · PHASE2 · COMPLETED · sponsor: **Incyte Corporation** · enrollment: 171 (actual)

## Conditions studied

- NonSegmental Vitiligo

## Interventions

- **DRUG:** INCB054707
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04818346
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-06
- **Primary completion:** 2022-05-24
- **Final completion:** 2023-05-24
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2024-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04818346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04818346, "A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04818346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*